Seeking Sales Account Managers Learn more.


News Updates

Visit us at the NIH Research Festival Exhibit Sept 17-18.  Booth: 265

Diffinity Genomics acquired by Chiral Technologies. 

Diffinity Genomics issued patent for their technology "Spatially inhomogenously functionalized porous media and method for use in selective removal of contaminants".  The patent was issued June 23, 2015. 

 Like us on facebook                                             


Chiral Technologies, Inc. Acquires Diffinity Genomics  

WEST CHESTER, Pa. (August 4, 2015) – Chiral Technologies, part of DAICEL CORPORATION, the global market leader in enantioselective chromatography, is pleased to announce the acquisition of the assets of Diffinity Genomics of West Henrietta, N.Y.   Read more...